>
Organization
Amgen, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Amgen, Inc.

... PR Newswire Amgen (NASDAQ:AMGN) today announced the submission of a Biologics License Application (BLA) to ...
... Allergan Plc Allergopharma GmbH & Co KG Allinaire Therapeutics LLC Almirall SA Amgen Inc Amphastar Pharmaceuticals Inc Amplia Therapeutics Ltd AnaMar AB AnaptysBio Inc AnGes ...
... Human therapeutics company Amgen (NASDAQ:AMGN) revealed on Friday the receipt of the US Food and Drug ...
... PR Newswire Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has ...
... Arabia, and rest of LAMEA). Key players profiled in the report include Amgen Inc., AstraZeneca PLC, Biogen, Inc., F. Hoffmann-La Roche Ltd. (Genentech, Inc.,), Horizon ...
... PR Newswire Amgen (NASDAQ:AMGN) and Direct Relief today announced a joint initiative in which Direct ...
... PR Newswire Amgen (NASDAQ:AMGN) today announced a novel multi-year collaboration with Magellan Rx Management, the ...
... PR Newswire Amgen (NASDAQ:AMGN) and the Lazarex Cancer Foundation, a non-profit organization focused on improving ...
... PR Newswire In November 2018, the Amgen Foundation expanded the Amgen Scholars Program (ASP) to 24 premier educational and research institutions worldwide. Tsinghua ...
... engineered to impact muscle function and contractility. Cytokinetics is collaborating with Amgen Inc. ("Amgen") to develop omecamtiv mecarbil, a novel cardiac muscle activator. Omecamtiv mecarbil ...
Subscribe now for full coverage on Amgen, Inc.
Start My Free Trial